IBDEI2NO ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44567,1,4,0)
 ;;=4^Z80.1
 ;;^UTILITY(U,$J,358.3,44567,2)
 ;;=^5063345
 ;;^UTILITY(U,$J,358.3,44568,0)
 ;;=Z80.3^^200^2229^34
 ;;^UTILITY(U,$J,358.3,44568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44568,1,3,0)
 ;;=3^Family Hx of Malig Neop of Breast
 ;;^UTILITY(U,$J,358.3,44568,1,4,0)
 ;;=4^Z80.3
 ;;^UTILITY(U,$J,358.3,44568,2)
 ;;=^5063347
 ;;^UTILITY(U,$J,358.3,44569,0)
 ;;=Z80.41^^200^2229^38
 ;;^UTILITY(U,$J,358.3,44569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44569,1,3,0)
 ;;=3^Family Hx of Malig Neop of Ovary
 ;;^UTILITY(U,$J,358.3,44569,1,4,0)
 ;;=4^Z80.41
 ;;^UTILITY(U,$J,358.3,44569,2)
 ;;=^5063348
 ;;^UTILITY(U,$J,358.3,44570,0)
 ;;=Z80.42^^200^2229^39
 ;;^UTILITY(U,$J,358.3,44570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44570,1,3,0)
 ;;=3^Family Hx of Malig Neop of Prostate
 ;;^UTILITY(U,$J,358.3,44570,1,4,0)
 ;;=4^Z80.42
 ;;^UTILITY(U,$J,358.3,44570,2)
 ;;=^5063349
 ;;^UTILITY(U,$J,358.3,44571,0)
 ;;=Z80.43^^200^2229^40
 ;;^UTILITY(U,$J,358.3,44571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44571,1,3,0)
 ;;=3^Family Hx of Malig Neop of Testis
 ;;^UTILITY(U,$J,358.3,44571,1,4,0)
 ;;=4^Z80.43
 ;;^UTILITY(U,$J,358.3,44571,2)
 ;;=^5063350
 ;;^UTILITY(U,$J,358.3,44572,0)
 ;;=Z80.6^^200^2229^32
 ;;^UTILITY(U,$J,358.3,44572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44572,1,3,0)
 ;;=3^Family Hx of Leukemia
 ;;^UTILITY(U,$J,358.3,44572,1,4,0)
 ;;=4^Z80.6
 ;;^UTILITY(U,$J,358.3,44572,2)
 ;;=^5063354
 ;;^UTILITY(U,$J,358.3,44573,0)
 ;;=Z80.8^^200^2229^37
 ;;^UTILITY(U,$J,358.3,44573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44573,1,3,0)
 ;;=3^Family Hx of Malig Neop of Organs/Systems
 ;;^UTILITY(U,$J,358.3,44573,1,4,0)
 ;;=4^Z80.8
 ;;^UTILITY(U,$J,358.3,44573,2)
 ;;=^5063356
 ;;^UTILITY(U,$J,358.3,44574,0)
 ;;=Z81.8^^200^2229^42
 ;;^UTILITY(U,$J,358.3,44574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44574,1,3,0)
 ;;=3^Family Hx of Mental/Behavioral Disorders
 ;;^UTILITY(U,$J,358.3,44574,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,44574,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,44575,0)
 ;;=Z82.3^^200^2229^49
 ;;^UTILITY(U,$J,358.3,44575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44575,1,3,0)
 ;;=3^Family Hx of Stroke
 ;;^UTILITY(U,$J,358.3,44575,1,4,0)
 ;;=4^Z82.3
 ;;^UTILITY(U,$J,358.3,44575,2)
 ;;=^5063367
 ;;^UTILITY(U,$J,358.3,44576,0)
 ;;=Z82.49^^200^2229^31
 ;;^UTILITY(U,$J,358.3,44576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44576,1,3,0)
 ;;=3^Family Hx of Ischemic Heart Disease/Circulatory System
 ;;^UTILITY(U,$J,358.3,44576,1,4,0)
 ;;=4^Z82.49
 ;;^UTILITY(U,$J,358.3,44576,2)
 ;;=^5063369
 ;;^UTILITY(U,$J,358.3,44577,0)
 ;;=Z82.5^^200^2229^22
 ;;^UTILITY(U,$J,358.3,44577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44577,1,3,0)
 ;;=3^Family Hx of Asthma/Chronic Lower Respiratory Diseases
 ;;^UTILITY(U,$J,358.3,44577,1,4,0)
 ;;=4^Z82.5
 ;;^UTILITY(U,$J,358.3,44577,2)
 ;;=^5063370
 ;;^UTILITY(U,$J,358.3,44578,0)
 ;;=Z82.61^^200^2229^21
 ;;^UTILITY(U,$J,358.3,44578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44578,1,3,0)
 ;;=3^Family Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,44578,1,4,0)
 ;;=4^Z82.61
 ;;^UTILITY(U,$J,358.3,44578,2)
 ;;=^5063371
 ;;^UTILITY(U,$J,358.3,44579,0)
 ;;=Z82.69^^200^2229^44
 ;;^UTILITY(U,$J,358.3,44579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44579,1,3,0)
 ;;=3^Family Hx of Musculoskeletal System/Connective Tissue
 ;;^UTILITY(U,$J,358.3,44579,1,4,0)
 ;;=4^Z82.69
 ;;^UTILITY(U,$J,358.3,44579,2)
 ;;=^5063373
 ;;^UTILITY(U,$J,358.3,44580,0)
 ;;=Z83.3^^200^2229^28
 ;;^UTILITY(U,$J,358.3,44580,1,0)
 ;;=^358.31IA^4^2
